226 related articles for article (PubMed ID: 2694978)
21. [Toxocariasis in Poznan region, Poland, in years 1990-2000].
Pawłowski ZS; Mizgajska H
Przegl Epidemiol; 2002; 56(4):559-65. PubMed ID: 12666581
[TBL] [Abstract][Full Text] [Related]
22. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection.
Leonardi D; Echenique C; Lamas MC; Salomon CJ
J Antimicrob Chemother; 2009 Aug; 64(2):375-8. PubMed ID: 19497941
[TBL] [Abstract][Full Text] [Related]
23. A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay.
Elefant GR; Shimizu SH; Sanchez MC; Jacob CM; Ferreira AW
J Clin Lab Anal; 2006; 20(4):164-72. PubMed ID: 16874812
[TBL] [Abstract][Full Text] [Related]
24. Myocarditis associated with visceral larva migrans due to Toxocara canis.
Abe K; Shimokawa H; Kubota T; Nawa Y; Takeshita A
Intern Med; 2002 Sep; 41(9):706-8. PubMed ID: 12322796
[TBL] [Abstract][Full Text] [Related]
25. Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy.
Albanese G; Venturi C; Galbiati G
Int J Dermatol; 2001 Jan; 40(1):67-71. PubMed ID: 11277961
[TBL] [Abstract][Full Text] [Related]
26. Chronic eosinophilic pneumonia due to visceral larva migrans.
Inoue K; Inoue Y; Arai T; Nawa Y; Kashiwa Y; Yamamoto S; Sakatani M
Intern Med; 2002 Jun; 41(6):478-82. PubMed ID: 12135183
[TBL] [Abstract][Full Text] [Related]
27. [Visceral larva migrans syndromes: reflections on various cases of toxocariasis].
Zenaidi N; Hamrioui B; Belkaid M; Tabet-Derraz O
Arch Inst Pasteur Alger; 1992; 58():273-81. PubMed ID: 1309143
[TBL] [Abstract][Full Text] [Related]
28. Visceral larva Migrans in a Young Italian Patient: A Diagnostic Dilemma.
Francalanci E; Manciulli T; Bandini G; Blanc P; Bonelli SI; Brunetti E; Gotuzzo E; Cretu CM; Gobbi F; Bartoloni A; Zammarchi L
Acta Parasitol; 2023 Dec; 68(4):937-941. PubMed ID: 37872438
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller.
Blackwell V; Vega-Lopez F
Br J Dermatol; 2001 Sep; 145(3):434-7. PubMed ID: 11531833
[TBL] [Abstract][Full Text] [Related]
30. The kinetic profile of clinical and laboratory findings and treatment outcome of patients with toxocariasis.
Phuc LDV; Hai TX; Loi CB; Quang HH; Vinh LD; Le TA
Trop Med Int Health; 2021 Nov; 26(11):1419-1426. PubMed ID: 34370367
[TBL] [Abstract][Full Text] [Related]
31. [Case of Toxocara canis larva migrans cured by additional treatment with albendazole].
Takamatsu K; Sumitani M; Nanjyou S; Nishijima M; Syoji S; Takifuji N; Kiyota H; Daga H; Takeda K
Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):836-41. PubMed ID: 19044036
[TBL] [Abstract][Full Text] [Related]
32. Hepatic imaging studies on patients with visceral larva migrans due to probable Ascaris suum infection.
Hayashi K; Tahara H; Yamashita K; Kuroki K; Matsushita R; Yamamoto S; Hori T; Hirono S; Nawa Y; Tsubouchi H
Abdom Imaging; 1999; 24(5):465-9. PubMed ID: 10475929
[TBL] [Abstract][Full Text] [Related]
33. [Visceral larval migrans (Human toxocariasis) cause of hypereosinophilia and visceral granulomas in adults].
Sapunar J; Fardella P
Bol Chil Parasitol; 1999; 54(1-2):21-4. PubMed ID: 10488586
[TBL] [Abstract][Full Text] [Related]
34. Current treatment recommendations for cutaneous larva migrans.
Rodilla F; Colomina J; Magraner J
Ann Pharmacother; 1994 May; 28(5):672-3. PubMed ID: 8069011
[No Abstract] [Full Text] [Related]
35. Treatment of cutaneous larva migrans.
Hepburn D; Nicholls DS
N Z Med J; 1990 Oct; 103(900):518. PubMed ID: 2234658
[No Abstract] [Full Text] [Related]
36. Toxocariasis diagnosed in international travelers at the Institute of Tropical Medicine, Antwerp, Belgium, from 2000 to 2013.
Van Den Broucke S; Kanobana K; Polman K; Soentjens P; Vekemans M; Theunissen C; Vlieghe E; Van Esbroeck M; Jacobs J; Van Den Enden E; Van Den Ende J; Van Gompel A; Clerinx J; Bottieau E
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003559. PubMed ID: 25746418
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka.
Iddawela D; Ehambaram K; Bandara P
BMC Ophthalmol; 2017 Apr; 17(1):50. PubMed ID: 28438141
[TBL] [Abstract][Full Text] [Related]
38. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans.
Caumes E; Carriere J; Datry A; Gaxotte P; Danis M; Gentilini M
Am J Trop Med Hyg; 1993 Nov; 49(5):641-4. PubMed ID: 8250105
[TBL] [Abstract][Full Text] [Related]
39. Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the Diaphragm.
Kakimoto M; Murata M; Mitsumoto-Kaseida F; Ogawa E; Matsumoto Y; Kusaga A; Toyoda K; Hayashi T; Ura K; Kanno K; Furusyo N; Tazuma S
Intern Med; 2019 Sep; 58(18):2737-2741. PubMed ID: 31178505
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of human toxocariasis (visceral larva migrans).
El-Shazly AM; Abdel Baset SM; Kamal A; Mohammed KA; Sakrs TI; Hammad SM
J Egypt Soc Parasitol; 2009 Dec; 39(3):731-44. PubMed ID: 20120741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
